US pharma group Emergent BioSolutions has completed the acquisition of Dublin-headquartered Adapt Pharma for the $635 million (€549 million). Adapt i(...)

A man administers Adapt Pharma’s Narcan as they try to revive a man who overdosed on heroin in Philadelphia. The man later came to and was taken to the hospital. Photograph:  Spencer Platt/Getty Images

Adapt Pharma, the Irish company behind emergency overdose treatment Narcan, has been sold in a $635 million deal. The Irish shareholders of the busin(...)